All research
2026-07-06 PubMed

Poly-arginine-11 (R11) Edge-Grafting Preserves Aromatic Drug Loading on Graphene Nanocarriers

Edge-Grafted Polyarginine Functionalization of Graphene Nanocarriers Maintains Noncovalent Aromatic Drug Loading.

Background

Effective drug delivery often faces challenges with cellular membrane permeability, a barrier that cell-penetrating peptides (CPPs) are known to overcome. While CPPs enhance cellular uptake, their functionalization on nanocarriers can interfere with drug loading, especially when drugs bind via noncovalent π-π interactions on surfaces like graphene. This conflict arises because peptide grafting might occupy or alter the very surface required for drug adsorption. Addressing this, researchers sought an orthogonal functionalization strategy to leverage CPP benefits without compromising the crucial π-conjugated molecule binding sites on graphene-based nanocarriers.

Study Design

Researchers developed an orthogonal functionalization strategy, covalently immobilizing Poly-arginine-11 (R11) selectively at the carboxylic acid-rich edges of graphene nanoparticles (B60). This design aimed to preserve the basal plane for π-π interactions. They then evaluated the loading and thermally induced release of two π-conjugated cargo molecules: 1-pyrenecarboxylic acid and compound 8, a NEK6 inhibitor. Spectroscopic and microscopic analyses were employed to confirm the integrity and accessibility of the basal plane post-functionalization, complemented by Molecular dynamics simulations to model peptide chain behavior and interactions with the graphene surface.

Results

The study demonstrated that R11 grafting at the edges of graphene nanoparticles did not affect the loading capacity or thermally induced release of aromatic drugs. Spectroscopic and microscopic analyses confirmed that the basal plane remained intact and accessible for π-π interactions after peptide functionalization. Molecular dynamics simulations provided insights into the mechanism, indicating that the R11 peptide chains formed a flexible, charged corona specifically at the nanoparticle periphery. This peripheral localization was crucial, as it prevented any perturbation of the molecule-graphene interactions essential for drug binding.

This orthogonal functionalization strategy successfully preserved the aromatic surface for π-π interactions, allowing for efficient drug binding while incorporating a cell-penetrating peptide.

Key Findings

  • Poly-arginine-11 (R11) was covalently immobilized selectively at the carboxylic acid-rich edges of graphene nanoparticles.
  • R11 grafting did not affect the loading capacity of π-conjugated aromatic drugs on the graphene basal plane.
  • Thermally induced release kinetics of aromatic drugs remained unaffected by R11 functionalization.
  • Spectroscopic and microscopic analyses confirmed the graphene basal plane remained intact and accessible after R11 grafting.
  • Molecular dynamics simulations showed R11 formed a flexible, charged corona at the periphery, not perturbing drug-graphene interactions.

Why It Matters

This novel edge-grafting strategy offers a significant advancement for designing peptide-graphene hybrid systems capable of delivering poorly soluble aromatic bioactive compounds. For peptide users and biohackers, this means future nanocarrier systems could combine the enhanced cellular uptake provided by CPPs like R11 with efficient loading of hydrophobic drugs, overcoming a long-standing challenge in drug formulation. This approach enables dual functionality in nanocarriers, allowing both improved cellular penetration and high drug payload retention. It moves closer to a usable protocol for creating more effective and targeted delivery systems, particularly for compounds relying on π-π interactions for loading.


poly-arginine-11 r11 graphene nanocarriers drug-delivery cell-penetrating-peptide
Source: pubmed:42402383 · Ingested 2026-07-06 · Digest: gemini-2.5-flash